Ensign Peak Advisors
NGM

Ensign Peak Advisors’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Ensign Peak Advisors’s Portfolio NGM Stock Details NGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,260
Closed -$43K – 2286
2022
Q3 		$43K Hold
3,260
– – ﹤0.01% 2240
2022
Q2 		$42K Hold
3,260
– – ﹤0.01% 2084
2022
Q1 		$50K Hold
3,260
– – ﹤0.01% 2131
2021
Q4 		$58K Buy
+3,260
New +$58K ﹤0.01% 2129